Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial (Q30080035)
scientific article published on 24 July 2010
Language:
(P31) (Q13442814)
(P50) (Q21264574)
(Q63032640)
(Q51026477)
(P304) 235-44
(P407) (Q1860)
(P433) 9737
(P478) 376
(P577) Saturday, July 24, 2010
(P921) (Q7083106)
(Q128581)
(P1433) (Q939416)
(P1476) "Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial" (language: en)
(P2093) Tutt A
Garber JE
Domchek SM
Audeh MW
Friedlander M
Arun B
Loman N
Wardley A
Mitchell G
Earl H
Wickens M
Carmichael J
(P2860) (Q40875071)
(Q34223870)
(Q24645441)
(Q28115843)
(Q29616290)
(Q34568554)
(Q29614844)
(Q34081887)
(Q29618799)
(Q22242910)
(Q34163219)
(Q57274824)
(Q35901185)
(Q72046532)
(Q63362916)
(Q28268061)
(Q27860519)
(Q28131711)
(Q27851474)
(Q27860904)
(Q24800411)
(Q43974233)
(Q29619615)
(Q33476082)
(Q44764054)
(Q33491991)
(Q80558331)
(Q28268169)
(Q36958682)
(Q37369575)
(Q37172320)
(Q39712677)
(Q36042091)
other details
description scientific article published on 24 July 2010

External Links